YaSheng Group (HERB) Stock Competitors & Peer Comparison
See (HERB) competitors and their performances in Stock Market.
Peer Comparison Table: Agricultural Farm Products Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| HERB | $0.03 | -25.00% | 4.7M | 0.02 | $1.23 | N/A |
| WLMIF | $2.66 | +0.19% | 16.6B | 11.57 | $0.23 | +4.11% |
| WLMIY | $26.24 | -3.38% | 16.4B | 11.62 | $2.26 | +4.17% |
| MNHVF | $21.89 | +0.00% | 11.5B | 11.64 | $1.88 | +3.19% |
| MHGVY | $20.09 | -4.11% | 10.6B | 10.61 | $1.89 | +3.48% |
| SALRY | $14.06 | -4.87% | 7.6B | 34.27 | $0.41 | +3.85% |
| SALRF | $55.50 | +0.00% | 7.5B | 33.84 | $1.64 | +3.92% |
| KLKBF | $6.17 | +0.00% | 6.8B | 11.43 | $0.54 | +2.41% |
| KLKBY | $5.50 | +0.00% | 6.1B | 25.00 | $0.22 | +2.17% |
| CPOUF | $0.70 | +0.00% | 5.3B | 7.00 | $0.10 | +5.53% |
Stock Comparison
HERB vs WLMIF Comparison June 2026
HERB plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HERB stands at 4.7M. In comparison, WLMIF has a market cap of 16.6B. Regarding current trading prices, HERB is priced at $0.03, while WLMIF trades at $2.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HERB currently has a P/E ratio of 0.02, whereas WLMIF's P/E ratio is 11.57. In terms of profitability, HERB's ROE is +0.03%, compared to WLMIF's ROE of +0.04%. Regarding short-term risk, HERB is more volatile compared to WLMIF. This indicates potentially higher risk in terms of short-term price fluctuations for HERB.Check WLMIF's competition here
HERB vs WLMIY Comparison June 2026
HERB plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HERB stands at 4.7M. In comparison, WLMIY has a market cap of 16.4B. Regarding current trading prices, HERB is priced at $0.03, while WLMIY trades at $26.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HERB currently has a P/E ratio of 0.02, whereas WLMIY's P/E ratio is 11.62. In terms of profitability, HERB's ROE is +0.03%, compared to WLMIY's ROE of +0.04%. Regarding short-term risk, HERB is more volatile compared to WLMIY. This indicates potentially higher risk in terms of short-term price fluctuations for HERB.Check WLMIY's competition here
HERB vs MNHVF Comparison June 2026
HERB plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HERB stands at 4.7M. In comparison, MNHVF has a market cap of 11.5B. Regarding current trading prices, HERB is priced at $0.03, while MNHVF trades at $21.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HERB currently has a P/E ratio of 0.02, whereas MNHVF's P/E ratio is 11.64. In terms of profitability, HERB's ROE is +0.03%, compared to MNHVF's ROE of +0.21%. Regarding short-term risk, HERB is more volatile compared to MNHVF. This indicates potentially higher risk in terms of short-term price fluctuations for HERB.Check MNHVF's competition here
HERB vs MHGVY Comparison June 2026
HERB plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HERB stands at 4.7M. In comparison, MHGVY has a market cap of 10.6B. Regarding current trading prices, HERB is priced at $0.03, while MHGVY trades at $20.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HERB currently has a P/E ratio of 0.02, whereas MHGVY's P/E ratio is 10.61. In terms of profitability, HERB's ROE is +0.03%, compared to MHGVY's ROE of +0.21%. Regarding short-term risk, HERB is more volatile compared to MHGVY. This indicates potentially higher risk in terms of short-term price fluctuations for HERB.Check MHGVY's competition here
HERB vs SALRY Comparison June 2026
HERB plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HERB stands at 4.7M. In comparison, SALRY has a market cap of 7.6B. Regarding current trading prices, HERB is priced at $0.03, while SALRY trades at $14.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HERB currently has a P/E ratio of 0.02, whereas SALRY's P/E ratio is 34.27. In terms of profitability, HERB's ROE is +0.03%, compared to SALRY's ROE of +0.12%. Regarding short-term risk, HERB is more volatile compared to SALRY. This indicates potentially higher risk in terms of short-term price fluctuations for HERB.Check SALRY's competition here
HERB vs SALRF Comparison June 2026
HERB plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HERB stands at 4.7M. In comparison, SALRF has a market cap of 7.5B. Regarding current trading prices, HERB is priced at $0.03, while SALRF trades at $55.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HERB currently has a P/E ratio of 0.02, whereas SALRF's P/E ratio is 33.84. In terms of profitability, HERB's ROE is +0.03%, compared to SALRF's ROE of +0.12%. Regarding short-term risk, HERB is more volatile compared to SALRF. This indicates potentially higher risk in terms of short-term price fluctuations for HERB.Check SALRF's competition here
HERB vs KLKBF Comparison June 2026
HERB plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HERB stands at 4.7M. In comparison, KLKBF has a market cap of 6.8B. Regarding current trading prices, HERB is priced at $0.03, while KLKBF trades at $6.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HERB currently has a P/E ratio of 0.02, whereas KLKBF's P/E ratio is 11.43. In terms of profitability, HERB's ROE is +0.03%, compared to KLKBF's ROE of +0.08%. Regarding short-term risk, HERB is more volatile compared to KLKBF. This indicates potentially higher risk in terms of short-term price fluctuations for HERB.Check KLKBF's competition here
HERB vs KLKBY Comparison June 2026
HERB plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HERB stands at 4.7M. In comparison, KLKBY has a market cap of 6.1B. Regarding current trading prices, HERB is priced at $0.03, while KLKBY trades at $5.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HERB currently has a P/E ratio of 0.02, whereas KLKBY's P/E ratio is 25.00. In terms of profitability, HERB's ROE is +0.03%, compared to KLKBY's ROE of +0.08%. Regarding short-term risk, HERB is more volatile compared to KLKBY. This indicates potentially higher risk in terms of short-term price fluctuations for HERB.Check KLKBY's competition here
HERB vs CPOUF Comparison June 2026
HERB plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HERB stands at 4.7M. In comparison, CPOUF has a market cap of 5.3B. Regarding current trading prices, HERB is priced at $0.03, while CPOUF trades at $0.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HERB currently has a P/E ratio of 0.02, whereas CPOUF's P/E ratio is 7.00. In terms of profitability, HERB's ROE is +0.03%, compared to CPOUF's ROE of +0.09%. Regarding short-term risk, HERB is more volatile compared to CPOUF. This indicates potentially higher risk in terms of short-term price fluctuations for HERB.Check CPOUF's competition here
HERB vs CHPFF Comparison June 2026
HERB plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HERB stands at 4.7M. In comparison, CHPFF has a market cap of 4.6B. Regarding current trading prices, HERB is priced at $0.03, while CHPFF trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HERB currently has a P/E ratio of 0.02, whereas CHPFF's P/E ratio is 6.88. In terms of profitability, HERB's ROE is +0.03%, compared to CHPFF's ROE of +0.09%. Regarding short-term risk, HERB is more volatile compared to CHPFF. This indicates potentially higher risk in terms of short-term price fluctuations for HERB.Check CHPFF's competition here
HERB vs PPOKF Comparison June 2026
HERB plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HERB stands at 4.7M. In comparison, PPOKF has a market cap of 4.1B. Regarding current trading prices, HERB is priced at $0.03, while PPOKF trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HERB currently has a P/E ratio of 0.02, whereas PPOKF's P/E ratio is 12.50. In terms of profitability, HERB's ROE is +0.03%, compared to PPOKF's ROE of +0.20%. Regarding short-term risk, HERB is less volatile compared to PPOKF. This indicates potentially lower risk in terms of short-term price fluctuations for HERB.Check PPOKF's competition here
HERB vs FTROF Comparison June 2026
HERB plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HERB stands at 4.7M. In comparison, FTROF has a market cap of 3.5B. Regarding current trading prices, HERB is priced at $0.03, while FTROF trades at $2.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HERB currently has a P/E ratio of 0.02, whereas FTROF's P/E ratio is 9.83. In terms of profitability, HERB's ROE is +0.03%, compared to FTROF's ROE of +0.15%. Regarding short-term risk, HERB is more volatile compared to FTROF. This indicates potentially higher risk in terms of short-term price fluctuations for HERB.Check FTROF's competition here
HERB vs FSRCY Comparison June 2026
HERB plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HERB stands at 4.7M. In comparison, FSRCY has a market cap of 3.2B. Regarding current trading prices, HERB is priced at $0.03, while FSRCY trades at $204.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HERB currently has a P/E ratio of 0.02, whereas FSRCY's P/E ratio is 8.93. In terms of profitability, HERB's ROE is +0.03%, compared to FSRCY's ROE of +0.15%. Regarding short-term risk, HERB is more volatile compared to FSRCY. This indicates potentially higher risk in terms of short-term price fluctuations for HERB.Check FSRCY's competition here
HERB vs KNKZF Comparison June 2026
HERB plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HERB stands at 4.7M. In comparison, KNKZF has a market cap of 2.8B. Regarding current trading prices, HERB is priced at $0.03, while KNKZF trades at $84.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HERB currently has a P/E ratio of 0.02, whereas KNKZF's P/E ratio is 15.28. In terms of profitability, HERB's ROE is +0.03%, compared to KNKZF's ROE of +0.09%. Regarding short-term risk, HERB is more volatile compared to KNKZF. This indicates potentially higher risk in terms of short-term price fluctuations for HERB.Check KNKZF's competition here
HERB vs BKFKF Comparison June 2026
HERB plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HERB stands at 4.7M. In comparison, BKFKF has a market cap of 2.7B. Regarding current trading prices, HERB is priced at $0.03, while BKFKF trades at $46.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HERB currently has a P/E ratio of 0.02, whereas BKFKF's P/E ratio is 20.81. In terms of profitability, HERB's ROE is +0.03%, compared to BKFKF's ROE of +0.08%. Regarding short-term risk, HERB is more volatile compared to BKFKF. This indicates potentially higher risk in terms of short-term price fluctuations for HERB.Check BKFKF's competition here
HERB vs GARPF Comparison June 2026
HERB plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HERB stands at 4.7M. In comparison, GARPF has a market cap of 2.7B. Regarding current trading prices, HERB is priced at $0.03, while GARPF trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HERB currently has a P/E ratio of 0.02, whereas GARPF's P/E ratio is 7.00. In terms of profitability, HERB's ROE is +0.03%, compared to GARPF's ROE of +0.06%. Regarding short-term risk, HERB is more volatile compared to GARPF. This indicates potentially higher risk in terms of short-term price fluctuations for HERB.Check GARPF's competition here
HERB vs GARPY Comparison June 2026
HERB plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HERB stands at 4.7M. In comparison, GARPY has a market cap of 2.5B. Regarding current trading prices, HERB is priced at $0.03, while GARPY trades at $20.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HERB currently has a P/E ratio of 0.02, whereas GARPY's P/E ratio is 6.33. In terms of profitability, HERB's ROE is +0.03%, compared to GARPY's ROE of +0.06%. Regarding short-term risk, HERB is more volatile compared to GARPY. This indicates potentially higher risk in terms of short-term price fluctuations for HERB.Check GARPY's competition here
HERB vs UPBMF Comparison June 2026
HERB plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HERB stands at 4.7M. In comparison, UPBMF has a market cap of 2.2B. Regarding current trading prices, HERB is priced at $0.03, while UPBMF trades at $3.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HERB currently has a P/E ratio of 0.02, whereas UPBMF's P/E ratio is 14.03. In terms of profitability, HERB's ROE is +0.03%, compared to UPBMF's ROE of +0.29%. Regarding short-term risk, HERB is less volatile compared to UPBMF. This indicates potentially lower risk in terms of short-term price fluctuations for HERB.Check UPBMF's competition here
HERB vs ASTVF Comparison June 2026
HERB plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HERB stands at 4.7M. In comparison, ASTVF has a market cap of 1.8B. Regarding current trading prices, HERB is priced at $0.03, while ASTVF trades at $8.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HERB currently has a P/E ratio of 0.02, whereas ASTVF's P/E ratio is 17.86. In terms of profitability, HERB's ROE is +0.03%, compared to ASTVF's ROE of +0.06%. Regarding short-term risk, HERB is more volatile compared to ASTVF. This indicates potentially higher risk in terms of short-term price fluctuations for HERB.Check ASTVF's competition here
HERB vs SLCJY Comparison June 2026
HERB plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HERB stands at 4.7M. In comparison, SLCJY has a market cap of 1.5B. Regarding current trading prices, HERB is priced at $0.03, while SLCJY trades at $2.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HERB currently has a P/E ratio of 0.02, whereas SLCJY's P/E ratio is 22.54. In terms of profitability, HERB's ROE is +0.03%, compared to SLCJY's ROE of +0.06%. Regarding short-term risk, HERB is more volatile compared to SLCJY. This indicates potentially higher risk in terms of short-term price fluctuations for HERB.Check SLCJY's competition here
HERB vs DNDPF Comparison June 2026
HERB plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HERB stands at 4.7M. In comparison, DNDPF has a market cap of 1.3B. Regarding current trading prices, HERB is priced at $0.03, while DNDPF trades at $14.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HERB currently has a P/E ratio of 0.02, whereas DNDPF's P/E ratio is -35.89. In terms of profitability, HERB's ROE is +0.03%, compared to DNDPF's ROE of -0.12%. Regarding short-term risk, HERB is more volatile compared to DNDPF. This indicates potentially higher risk in terms of short-term price fluctuations for HERB.Check DNDPF's competition here
HERB vs MHPSY Comparison June 2026
HERB plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HERB stands at 4.7M. In comparison, MHPSY has a market cap of 1B. Regarding current trading prices, HERB is priced at $0.03, while MHPSY trades at $9.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HERB currently has a P/E ratio of 0.02, whereas MHPSY's P/E ratio is 5.92. In terms of profitability, HERB's ROE is +0.03%, compared to MHPSY's ROE of +0.08%. Regarding short-term risk, HERB is more volatile compared to MHPSY. This indicates potentially higher risk in terms of short-term price fluctuations for HERB.Check MHPSY's competition here
HERB vs CTTQF Comparison June 2026
HERB plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HERB stands at 4.7M. In comparison, CTTQF has a market cap of 985.2M. Regarding current trading prices, HERB is priced at $0.03, while CTTQF trades at $2.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HERB currently has a P/E ratio of 0.02, whereas CTTQF's P/E ratio is 70.67. In terms of profitability, HERB's ROE is +0.03%, compared to CTTQF's ROE of +0.04%. Regarding short-term risk, HERB is more volatile compared to CTTQF. This indicates potentially higher risk in terms of short-term price fluctuations for HERB.Check CTTQF's competition here
HERB vs AEPLF Comparison June 2026
HERB plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HERB stands at 4.7M. In comparison, AEPLF has a market cap of 973.7M. Regarding current trading prices, HERB is priced at $0.03, while AEPLF trades at $25.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HERB currently has a P/E ratio of 0.02, whereas AEPLF's P/E ratio is 10.98. In terms of profitability, HERB's ROE is +0.03%, compared to AEPLF's ROE of +0.16%. Regarding short-term risk, HERB is more volatile compared to AEPLF. This indicates potentially higher risk in terms of short-term price fluctuations for HERB.Check AEPLF's competition here
HERB vs GRGSF Comparison June 2026
HERB plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HERB stands at 4.7M. In comparison, GRGSF has a market cap of 894.6M. Regarding current trading prices, HERB is priced at $0.03, while GRGSF trades at $7.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HERB currently has a P/E ratio of 0.02, whereas GRGSF's P/E ratio is -66.42. In terms of profitability, HERB's ROE is +0.03%, compared to GRGSF's ROE of -0.10%. Regarding short-term risk, HERB is more volatile compared to GRGSF. This indicates potentially higher risk in terms of short-term price fluctuations for HERB.Check GRGSF's competition here
HERB vs AAGRY Comparison June 2026
HERB plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HERB stands at 4.7M. In comparison, AAGRY has a market cap of 885.4M. Regarding current trading prices, HERB is priced at $0.03, while AAGRY trades at $2.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HERB currently has a P/E ratio of 0.02, whereas AAGRY's P/E ratio is 10.00. In terms of profitability, HERB's ROE is +0.03%, compared to AAGRY's ROE of +0.07%. Regarding short-term risk, HERB is more volatile compared to AAGRY. This indicates potentially higher risk in terms of short-term price fluctuations for HERB.Check AAGRY's competition here
HERB vs GRCLF Comparison June 2026
HERB plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HERB stands at 4.7M. In comparison, GRCLF has a market cap of 867M. Regarding current trading prices, HERB is priced at $0.03, while GRCLF trades at $3.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HERB currently has a P/E ratio of 0.02, whereas GRCLF's P/E ratio is -97.75. In terms of profitability, HERB's ROE is +0.03%, compared to GRCLF's ROE of -0.01%. Regarding short-term risk, HERB is more volatile compared to GRCLF. This indicates potentially higher risk in terms of short-term price fluctuations for HERB.Check GRCLF's competition here
HERB vs MRVSY Comparison June 2026
HERB plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HERB stands at 4.7M. In comparison, MRVSY has a market cap of 777.6M. Regarding current trading prices, HERB is priced at $0.03, while MRVSY trades at $3.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HERB currently has a P/E ratio of 0.02, whereas MRVSY's P/E ratio is 8.29. In terms of profitability, HERB's ROE is +0.03%, compared to MRVSY's ROE of +0.54%. Regarding short-term risk, HERB is more volatile compared to MRVSY. This indicates potentially higher risk in terms of short-term price fluctuations for HERB.Check MRVSY's competition here
HERB vs EDESY Comparison June 2026
HERB plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HERB stands at 4.7M. In comparison, EDESY has a market cap of 729.1M. Regarding current trading prices, HERB is priced at $0.03, while EDESY trades at $19.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HERB currently has a P/E ratio of 0.02, whereas EDESY's P/E ratio is 15.18. In terms of profitability, HERB's ROE is +0.03%, compared to EDESY's ROE of +0.05%. Regarding short-term risk, HERB is less volatile compared to EDESY. This indicates potentially lower risk in terms of short-term price fluctuations for HERB.Check EDESY's competition here
HERB vs PTABF Comparison June 2026
HERB plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HERB stands at 4.7M. In comparison, PTABF has a market cap of 692.9M. Regarding current trading prices, HERB is priced at $0.03, while PTABF trades at $0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HERB currently has a P/E ratio of 0.02, whereas PTABF's P/E ratio is 9.00. In terms of profitability, HERB's ROE is +0.03%, compared to PTABF's ROE of +0.07%. Regarding short-term risk, HERB is more volatile compared to PTABF. This indicates potentially higher risk in terms of short-term price fluctuations for HERB.Check PTABF's competition here
HERB vs PPLFF Comparison June 2026
HERB plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HERB stands at 4.7M. In comparison, PPLFF has a market cap of 585.7M. Regarding current trading prices, HERB is priced at $0.03, while PPLFF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HERB currently has a P/E ratio of 0.02, whereas PPLFF's P/E ratio is 4.29. In terms of profitability, HERB's ROE is +0.03%, compared to PPLFF's ROE of +0.14%. Regarding short-term risk, HERB is more volatile compared to PPLFF. This indicates potentially higher risk in terms of short-term price fluctuations for HERB.Check PPLFF's competition here
HERB vs ASAGF Comparison June 2026
HERB plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HERB stands at 4.7M. In comparison, ASAGF has a market cap of 578.7M. Regarding current trading prices, HERB is priced at $0.03, while ASAGF trades at $0.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HERB currently has a P/E ratio of 0.02, whereas ASAGF's P/E ratio is 7.38. In terms of profitability, HERB's ROE is +0.03%, compared to ASAGF's ROE of +0.06%. Regarding short-term risk, HERB is more volatile compared to ASAGF. This indicates potentially higher risk in terms of short-term price fluctuations for HERB.Check ASAGF's competition here
HERB vs SISAF Comparison June 2026
HERB plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HERB stands at 4.7M. In comparison, SISAF has a market cap of 564.3M. Regarding current trading prices, HERB is priced at $0.03, while SISAF trades at $54.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HERB currently has a P/E ratio of 0.02, whereas SISAF's P/E ratio is 4.93. In terms of profitability, HERB's ROE is +0.03%, compared to SISAF's ROE of +0.13%. Regarding short-term risk, HERB is less volatile compared to SISAF. This indicates potentially lower risk in terms of short-term price fluctuations for HERB.Check SISAF's competition here
HERB vs ORENF Comparison June 2026
HERB plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HERB stands at 4.7M. In comparison, ORENF has a market cap of 556.2M. Regarding current trading prices, HERB is priced at $0.03, while ORENF trades at $5.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HERB currently has a P/E ratio of 0.02, whereas ORENF's P/E ratio is 12.03. In terms of profitability, HERB's ROE is +0.03%, compared to ORENF's ROE of +0.09%. Regarding short-term risk, HERB is more volatile compared to ORENF. This indicates potentially higher risk in terms of short-term price fluctuations for HERB.Check ORENF's competition here
HERB vs PPLFY Comparison June 2026
HERB plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HERB stands at 4.7M. In comparison, PPLFY has a market cap of 545.6M. Regarding current trading prices, HERB is priced at $0.03, while PPLFY trades at $4.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HERB currently has a P/E ratio of 0.02, whereas PPLFY's P/E ratio is 5.13. In terms of profitability, HERB's ROE is +0.03%, compared to PPLFY's ROE of +0.14%. Regarding short-term risk, HERB is more volatile compared to PPLFY. This indicates potentially higher risk in terms of short-term price fluctuations for HERB.Check PPLFY's competition here
HERB vs AAYYY Comparison June 2026
HERB plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HERB stands at 4.7M. In comparison, AAYYY has a market cap of 526.2M. Regarding current trading prices, HERB is priced at $0.03, while AAYYY trades at $8.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HERB currently has a P/E ratio of 0.02, whereas AAYYY's P/E ratio is 6.82. In terms of profitability, HERB's ROE is +0.03%, compared to AAYYY's ROE of +0.06%. Regarding short-term risk, HERB is more volatile compared to AAYYY. This indicates potentially higher risk in terms of short-term price fluctuations for HERB.Check AAYYY's competition here
HERB vs UVPOF Comparison June 2026
HERB plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HERB stands at 4.7M. In comparison, UVPOF has a market cap of 497.3M. Regarding current trading prices, HERB is priced at $0.03, while UVPOF trades at $0.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HERB currently has a P/E ratio of 0.02, whereas UVPOF's P/E ratio is 13.22. In terms of profitability, HERB's ROE is +0.03%, compared to UVPOF's ROE of +0.34%. Regarding short-term risk, HERB is more volatile compared to UVPOF. This indicates potentially higher risk in terms of short-term price fluctuations for HERB.Check UVPOF's competition here
HERB vs BRCPF Comparison June 2026
HERB plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HERB stands at 4.7M. In comparison, BRCPF has a market cap of 441.1M. Regarding current trading prices, HERB is priced at $0.03, while BRCPF trades at $4.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HERB currently has a P/E ratio of 0.02, whereas BRCPF's P/E ratio is 11.31. In terms of profitability, HERB's ROE is +0.03%, compared to BRCPF's ROE of -0.01%. Regarding short-term risk, HERB is more volatile compared to BRCPF. This indicates potentially higher risk in terms of short-term price fluctuations for HERB.Check BRCPF's competition here
HERB vs SLMCF Comparison June 2026
HERB plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HERB stands at 4.7M. In comparison, SLMCF has a market cap of 429.2M. Regarding current trading prices, HERB is priced at $0.03, while SLMCF trades at $5.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HERB currently has a P/E ratio of 0.02, whereas SLMCF's P/E ratio is 22.00. In terms of profitability, HERB's ROE is +0.03%, compared to SLMCF's ROE of -0.03%. Regarding short-term risk, HERB is more volatile compared to SLMCF. This indicates potentially higher risk in terms of short-term price fluctuations for HERB.Check SLMCF's competition here
HERB vs SARDY Comparison June 2026
HERB plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HERB stands at 4.7M. In comparison, SARDY has a market cap of 350.6M. Regarding current trading prices, HERB is priced at $0.03, while SARDY trades at $18.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HERB currently has a P/E ratio of 0.02, whereas SARDY's P/E ratio is 8.22. In terms of profitability, HERB's ROE is +0.03%, compared to SARDY's ROE of +0.10%. Regarding short-term risk, HERB is more volatile compared to SARDY. This indicates potentially higher risk in terms of short-term price fluctuations for HERB.Check SARDY's competition here
HERB vs SLCJF Comparison June 2026
HERB plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HERB stands at 4.7M. In comparison, SLCJF has a market cap of 339.6M. Regarding current trading prices, HERB is priced at $0.03, while SLCJF trades at $2.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HERB currently has a P/E ratio of 0.02, whereas SLCJF's P/E ratio is 7.82. In terms of profitability, HERB's ROE is +0.03%, compared to SLCJF's ROE of +0.10%. Regarding short-term risk, HERB is more volatile compared to SLCJF. This indicates potentially higher risk in terms of short-term price fluctuations for HERB.Check SLCJF's competition here
HERB vs ALFDF Comparison June 2026
HERB plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HERB stands at 4.7M. In comparison, ALFDF has a market cap of 284.7M. Regarding current trading prices, HERB is priced at $0.03, while ALFDF trades at $7.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HERB currently has a P/E ratio of 0.02, whereas ALFDF's P/E ratio is 9.35. In terms of profitability, HERB's ROE is +0.03%, compared to ALFDF's ROE of +0.17%. Regarding short-term risk, HERB is more volatile compared to ALFDF. This indicates potentially higher risk in terms of short-term price fluctuations for HERB.Check ALFDF's competition here
HERB vs SPZI Comparison June 2026
HERB plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HERB stands at 4.7M. In comparison, SPZI has a market cap of 273.9M. Regarding current trading prices, HERB is priced at $0.03, while SPZI trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HERB currently has a P/E ratio of 0.02, whereas SPZI's P/E ratio is -43.00. In terms of profitability, HERB's ROE is +0.03%, compared to SPZI's ROE of N/A. Regarding short-term risk, HERB is less volatile compared to SPZI. This indicates potentially lower risk in terms of short-term price fluctuations for HERB.Check SPZI's competition here
HERB vs SARDF Comparison June 2026
HERB plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HERB stands at 4.7M. In comparison, SARDF has a market cap of 259.9M. Regarding current trading prices, HERB is priced at $0.03, while SARDF trades at $2.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HERB currently has a P/E ratio of 0.02, whereas SARDF's P/E ratio is 7.13. In terms of profitability, HERB's ROE is +0.03%, compared to SARDF's ROE of +0.09%. Regarding short-term risk, HERB is more volatile compared to SARDF. This indicates potentially higher risk in terms of short-term price fluctuations for HERB.Check SARDF's competition here
HERB vs DDEJF Comparison June 2026
HERB plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HERB stands at 4.7M. In comparison, DDEJF has a market cap of 234.6M. Regarding current trading prices, HERB is priced at $0.03, while DDEJF trades at $2.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HERB currently has a P/E ratio of 0.02, whereas DDEJF's P/E ratio is 1.27. In terms of profitability, HERB's ROE is +0.03%, compared to DDEJF's ROE of +0.59%. Regarding short-term risk, HERB is more volatile compared to DDEJF. This indicates potentially higher risk in terms of short-term price fluctuations for HERB.Check DDEJF's competition here
HERB vs CAIHF Comparison June 2026
HERB plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HERB stands at 4.7M. In comparison, CAIHF has a market cap of 217.4M. Regarding current trading prices, HERB is priced at $0.03, while CAIHF trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HERB currently has a P/E ratio of 0.02, whereas CAIHF's P/E ratio is 2.80. In terms of profitability, HERB's ROE is +0.03%, compared to CAIHF's ROE of +0.11%. Regarding short-term risk, HERB is less volatile compared to CAIHF. This indicates potentially lower risk in terms of short-term price fluctuations for HERB.Check CAIHF's competition here
HERB vs STNT Comparison June 2026
HERB plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HERB stands at 4.7M. In comparison, STNT has a market cap of 162.5M. Regarding current trading prices, HERB is priced at $0.03, while STNT trades at $6.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HERB currently has a P/E ratio of 0.02, whereas STNT's P/E ratio is N/A. In terms of profitability, HERB's ROE is +0.03%, compared to STNT's ROE of +0.24%. Regarding short-term risk, HERB is more volatile compared to STNT. This indicates potentially higher risk in terms of short-term price fluctuations for HERB.Check STNT's competition here
HERB vs DNDEF Comparison June 2026
HERB plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HERB stands at 4.7M. In comparison, DNDEF has a market cap of 79.2M. Regarding current trading prices, HERB is priced at $0.03, while DNDEF trades at $15.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HERB currently has a P/E ratio of 0.02, whereas DNDEF's P/E ratio is -38.66. In terms of profitability, HERB's ROE is +0.03%, compared to DNDEF's ROE of -0.12%. Regarding short-term risk, HERB is more volatile compared to DNDEF. This indicates potentially higher risk in terms of short-term price fluctuations for HERB.Check DNDEF's competition here
HERB vs NNUTU Comparison June 2026
HERB plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HERB stands at 4.7M. In comparison, NNUTU has a market cap of 41.6M. Regarding current trading prices, HERB is priced at $0.03, while NNUTU trades at $3,750.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HERB currently has a P/E ratio of 0.02, whereas NNUTU's P/E ratio is 28.31. In terms of profitability, HERB's ROE is +0.03%, compared to NNUTU's ROE of N/A. Regarding short-term risk, HERB is more volatile compared to NNUTU. This indicates potentially higher risk in terms of short-term price fluctuations for HERB.Check NNUTU's competition here
HERB vs IDBHF Comparison June 2026
HERB plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HERB stands at 4.7M. In comparison, IDBHF has a market cap of 30M. Regarding current trading prices, HERB is priced at $0.03, while IDBHF trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HERB currently has a P/E ratio of 0.02, whereas IDBHF's P/E ratio is 0.14. In terms of profitability, HERB's ROE is +0.03%, compared to IDBHF's ROE of +0.08%. Regarding short-term risk, HERB is less volatile compared to IDBHF. This indicates potentially lower risk in terms of short-term price fluctuations for HERB.Check IDBHF's competition here
HERB vs OPTHF Comparison June 2026
HERB plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HERB stands at 4.7M. In comparison, OPTHF has a market cap of 22.8M. Regarding current trading prices, HERB is priced at $0.03, while OPTHF trades at $0.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HERB currently has a P/E ratio of 0.02, whereas OPTHF's P/E ratio is -5.88. In terms of profitability, HERB's ROE is +0.03%, compared to OPTHF's ROE of -0.57%. Regarding short-term risk, HERB is more volatile compared to OPTHF. This indicates potentially higher risk in terms of short-term price fluctuations for HERB.Check OPTHF's competition here
HERB vs CTUNF Comparison June 2026
HERB plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HERB stands at 4.7M. In comparison, CTUNF has a market cap of 18.5M. Regarding current trading prices, HERB is priced at $0.03, while CTUNF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HERB currently has a P/E ratio of 0.02, whereas CTUNF's P/E ratio is -0.57. In terms of profitability, HERB's ROE is +0.03%, compared to CTUNF's ROE of -0.45%. Regarding short-term risk, HERB is less volatile compared to CTUNF. This indicates potentially lower risk in terms of short-term price fluctuations for HERB.Check CTUNF's competition here
HERB vs CLAD Comparison June 2026
HERB plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HERB stands at 4.7M. In comparison, CLAD has a market cap of 15M. Regarding current trading prices, HERB is priced at $0.03, while CLAD trades at $1.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HERB currently has a P/E ratio of 0.02, whereas CLAD's P/E ratio is -33.67. In terms of profitability, HERB's ROE is +0.03%, compared to CLAD's ROE of +0.04%. Regarding short-term risk, HERB is more volatile compared to CLAD. This indicates potentially higher risk in terms of short-term price fluctuations for HERB.Check CLAD's competition here
HERB vs CMGHY Comparison June 2026
HERB plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HERB stands at 4.7M. In comparison, CMGHY has a market cap of 14.6M. Regarding current trading prices, HERB is priced at $0.03, while CMGHY trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HERB currently has a P/E ratio of 0.02, whereas CMGHY's P/E ratio is -8.84. In terms of profitability, HERB's ROE is +0.03%, compared to CMGHY's ROE of -0.08%. Regarding short-term risk, HERB is less volatile compared to CMGHY. This indicates potentially lower risk in terms of short-term price fluctuations for HERB.Check CMGHY's competition here
HERB vs PRCF Comparison June 2026
HERB plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HERB stands at 4.7M. In comparison, PRCF has a market cap of 12M. Regarding current trading prices, HERB is priced at $0.03, while PRCF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HERB currently has a P/E ratio of 0.02, whereas PRCF's P/E ratio is N/A. In terms of profitability, HERB's ROE is +0.03%, compared to PRCF's ROE of N/A. Regarding short-term risk, HERB is more volatile compared to PRCF. This indicates potentially higher risk in terms of short-term price fluctuations for HERB.Check PRCF's competition here
HERB vs PEASF Comparison June 2026
HERB plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HERB stands at 4.7M. In comparison, PEASF has a market cap of 7.1M. Regarding current trading prices, HERB is priced at $0.03, while PEASF trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HERB currently has a P/E ratio of 0.02, whereas PEASF's P/E ratio is -1.56. In terms of profitability, HERB's ROE is +0.03%, compared to PEASF's ROE of -1.02%. Regarding short-term risk, HERB is more volatile compared to PEASF. This indicates potentially higher risk in terms of short-term price fluctuations for HERB.Check PEASF's competition here
HERB vs IGPFF Comparison June 2026
HERB plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HERB stands at 4.7M. In comparison, IGPFF has a market cap of 5.4M. Regarding current trading prices, HERB is priced at $0.03, while IGPFF trades at $0.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HERB currently has a P/E ratio of 0.02, whereas IGPFF's P/E ratio is 35.35. In terms of profitability, HERB's ROE is +0.03%, compared to IGPFF's ROE of -0.39%. Regarding short-term risk, HERB is less volatile compared to IGPFF. This indicates potentially lower risk in terms of short-term price fluctuations for HERB.Check IGPFF's competition here
HERB vs MGNC Comparison June 2026
HERB plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HERB stands at 4.7M. In comparison, MGNC has a market cap of 4.9M. Regarding current trading prices, HERB is priced at $0.03, while MGNC trades at $0.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HERB currently has a P/E ratio of 0.02, whereas MGNC's P/E ratio is -19.50. In terms of profitability, HERB's ROE is +0.03%, compared to MGNC's ROE of -0.80%. Regarding short-term risk, HERB is more volatile compared to MGNC. This indicates potentially higher risk in terms of short-term price fluctuations for HERB.Check MGNC's competition here
HERB vs AASZF Comparison June 2026
HERB plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HERB stands at 4.7M. In comparison, AASZF has a market cap of 2.3M. Regarding current trading prices, HERB is priced at $0.03, while AASZF trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HERB currently has a P/E ratio of 0.02, whereas AASZF's P/E ratio is -0.01. In terms of profitability, HERB's ROE is +0.03%, compared to AASZF's ROE of -2.17%. Regarding short-term risk, HERB is less volatile compared to AASZF. This indicates potentially lower risk in terms of short-term price fluctuations for HERB.Check AASZF's competition here
HERB vs GCEH Comparison June 2026
HERB plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HERB stands at 4.7M. In comparison, GCEH has a market cap of 1.8M. Regarding current trading prices, HERB is priced at $0.03, while GCEH trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HERB currently has a P/E ratio of 0.02, whereas GCEH's P/E ratio is 0.02. In terms of profitability, HERB's ROE is +0.03%, compared to GCEH's ROE of +3.01%. Regarding short-term risk, HERB is less volatile compared to GCEH. This indicates potentially lower risk in terms of short-term price fluctuations for HERB.Check GCEH's competition here
HERB vs CMGHF Comparison June 2026
HERB plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HERB stands at 4.7M. In comparison, CMGHF has a market cap of 1.7M. Regarding current trading prices, HERB is priced at $0.03, while CMGHF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HERB currently has a P/E ratio of 0.02, whereas CMGHF's P/E ratio is -0.50. In terms of profitability, HERB's ROE is +0.03%, compared to CMGHF's ROE of -0.10%. Regarding short-term risk, HERB is more volatile compared to CMGHF. This indicates potentially higher risk in terms of short-term price fluctuations for HERB.Check CMGHF's competition here
HERB vs GSFD Comparison June 2026
HERB plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HERB stands at 4.7M. In comparison, GSFD has a market cap of 933K. Regarding current trading prices, HERB is priced at $0.03, while GSFD trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HERB currently has a P/E ratio of 0.02, whereas GSFD's P/E ratio is -0.16. In terms of profitability, HERB's ROE is +0.03%, compared to GSFD's ROE of -0.05%. Regarding short-term risk, HERB is more volatile compared to GSFD. This indicates potentially higher risk in terms of short-term price fluctuations for HERB.Check GSFD's competition here
HERB vs PNDHF Comparison June 2026
HERB plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HERB stands at 4.7M. In comparison, PNDHF has a market cap of 684.7K. Regarding current trading prices, HERB is priced at $0.03, while PNDHF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HERB currently has a P/E ratio of 0.02, whereas PNDHF's P/E ratio is -0.20. In terms of profitability, HERB's ROE is +0.03%, compared to PNDHF's ROE of +0.27%. Regarding short-term risk, HERB and PNDHF have similar daily volatility (28.57).Check PNDHF's competition here
HERB vs FLAF Comparison June 2026
HERB plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HERB stands at 4.7M. In comparison, FLAF has a market cap of 460.4K. Regarding current trading prices, HERB is priced at $0.03, while FLAF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HERB currently has a P/E ratio of 0.02, whereas FLAF's P/E ratio is -0.01. In terms of profitability, HERB's ROE is +0.03%, compared to FLAF's ROE of -4.06%. Regarding short-term risk, HERB is more volatile compared to FLAF. This indicates potentially higher risk in terms of short-term price fluctuations for HERB.Check FLAF's competition here
HERB vs FLLLF Comparison June 2026
HERB plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HERB stands at 4.7M. In comparison, FLLLF has a market cap of 308.7K. Regarding current trading prices, HERB is priced at $0.03, while FLLLF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HERB currently has a P/E ratio of 0.02, whereas FLLLF's P/E ratio is -1.67. In terms of profitability, HERB's ROE is +0.03%, compared to FLLLF's ROE of +0.23%. Regarding short-term risk, HERB is less volatile compared to FLLLF. This indicates potentially lower risk in terms of short-term price fluctuations for HERB.Check FLLLF's competition here
HERB vs MSRM Comparison June 2026
HERB plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HERB stands at 4.7M. In comparison, MSRM has a market cap of 244.1K. Regarding current trading prices, HERB is priced at $0.03, while MSRM trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HERB currently has a P/E ratio of 0.02, whereas MSRM's P/E ratio is -1.45. In terms of profitability, HERB's ROE is +0.03%, compared to MSRM's ROE of +2.80%. Regarding short-term risk, HERB is more volatile compared to MSRM. This indicates potentially higher risk in terms of short-term price fluctuations for HERB.Check MSRM's competition here
HERB vs MSAH Comparison June 2026
HERB plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HERB stands at 4.7M. In comparison, MSAH has a market cap of 241.2K. Regarding current trading prices, HERB is priced at $0.03, while MSAH trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HERB currently has a P/E ratio of 0.02, whereas MSAH's P/E ratio is 0.17. In terms of profitability, HERB's ROE is +0.03%, compared to MSAH's ROE of +0.38%. Regarding short-term risk, HERB is less volatile compared to MSAH. This indicates potentially lower risk in terms of short-term price fluctuations for HERB.Check MSAH's competition here
HERB vs RSSFF Comparison June 2026
HERB plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HERB stands at 4.7M. In comparison, RSSFF has a market cap of 189.2K. Regarding current trading prices, HERB is priced at $0.03, while RSSFF trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HERB currently has a P/E ratio of 0.02, whereas RSSFF's P/E ratio is -0.20. In terms of profitability, HERB's ROE is +0.03%, compared to RSSFF's ROE of +1.23%. Regarding short-term risk, HERB is less volatile compared to RSSFF. This indicates potentially lower risk in terms of short-term price fluctuations for HERB.Check RSSFF's competition here
HERB vs HERF Comparison June 2026
HERB plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HERB stands at 4.7M. In comparison, HERF has a market cap of 128.3K. Regarding current trading prices, HERB is priced at $0.03, while HERF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HERB currently has a P/E ratio of 0.02, whereas HERF's P/E ratio is N/A. In terms of profitability, HERB's ROE is +0.03%, compared to HERF's ROE of +0.00%. Regarding short-term risk, HERB is more volatile compared to HERF. This indicates potentially higher risk in terms of short-term price fluctuations for HERB.Check HERF's competition here
HERB vs SHMP Comparison June 2026
HERB plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HERB stands at 4.7M. In comparison, SHMP has a market cap of 127.8K. Regarding current trading prices, HERB is priced at $0.03, while SHMP trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HERB currently has a P/E ratio of 0.02, whereas SHMP's P/E ratio is -0.01. In terms of profitability, HERB's ROE is +0.03%, compared to SHMP's ROE of +1.16%. Regarding short-term risk, HERB is more volatile compared to SHMP. This indicates potentially higher risk in terms of short-term price fluctuations for HERB.Check SHMP's competition here
HERB vs STEV Comparison June 2026
HERB plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HERB stands at 4.7M. In comparison, STEV has a market cap of 56.9K. Regarding current trading prices, HERB is priced at $0.03, while STEV trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HERB currently has a P/E ratio of 0.02, whereas STEV's P/E ratio is -0.01. In terms of profitability, HERB's ROE is +0.03%, compared to STEV's ROE of +0.02%. Regarding short-term risk, HERB is less volatile compared to STEV. This indicates potentially lower risk in terms of short-term price fluctuations for HERB.Check STEV's competition here
HERB vs SUWN Comparison June 2026
HERB plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HERB stands at 4.7M. In comparison, SUWN has a market cap of 20K. Regarding current trading prices, HERB is priced at $0.03, while SUWN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HERB currently has a P/E ratio of 0.02, whereas SUWN's P/E ratio is -0.00. In terms of profitability, HERB's ROE is +0.03%, compared to SUWN's ROE of -0.49%. Regarding short-term risk, HERB is more volatile compared to SUWN. This indicates potentially higher risk in terms of short-term price fluctuations for HERB.Check SUWN's competition here
HERB vs SIAF Comparison June 2026
HERB plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HERB stands at 4.7M. In comparison, SIAF has a market cap of 18.1K. Regarding current trading prices, HERB is priced at $0.03, while SIAF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HERB currently has a P/E ratio of 0.02, whereas SIAF's P/E ratio is -0.00. In terms of profitability, HERB's ROE is +0.03%, compared to SIAF's ROE of -0.23%. Regarding short-term risk, HERB is more volatile compared to SIAF. This indicates potentially higher risk in terms of short-term price fluctuations for HERB.Check SIAF's competition here
HERB vs URYL Comparison June 2026
HERB plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HERB stands at 4.7M. In comparison, URYL has a market cap of 15.1K. Regarding current trading prices, HERB is priced at $0.03, while URYL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HERB currently has a P/E ratio of 0.02, whereas URYL's P/E ratio is N/A. In terms of profitability, HERB's ROE is +0.03%, compared to URYL's ROE of -4.37%. Regarding short-term risk, HERB is more volatile compared to URYL. This indicates potentially higher risk in terms of short-term price fluctuations for HERB.Check URYL's competition here
HERB vs CHYI Comparison June 2026
HERB plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HERB stands at 4.7M. In comparison, CHYI has a market cap of 13.7K. Regarding current trading prices, HERB is priced at $0.03, while CHYI trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HERB currently has a P/E ratio of 0.02, whereas CHYI's P/E ratio is -1.00. In terms of profitability, HERB's ROE is +0.03%, compared to CHYI's ROE of +14.52%. Regarding short-term risk, HERB is more volatile compared to CHYI. This indicates potentially higher risk in terms of short-term price fluctuations for HERB.Check CHYI's competition here
HERB vs OGAA Comparison June 2026
HERB plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HERB stands at 4.7M. In comparison, OGAA has a market cap of 9.3K. Regarding current trading prices, HERB is priced at $0.03, while OGAA trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HERB currently has a P/E ratio of 0.02, whereas OGAA's P/E ratio is -0.01. In terms of profitability, HERB's ROE is +0.03%, compared to OGAA's ROE of -2.82%. Regarding short-term risk, HERB is more volatile compared to OGAA. This indicates potentially higher risk in terms of short-term price fluctuations for HERB.Check OGAA's competition here
HERB vs HLKKF Comparison June 2026
HERB plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HERB stands at 4.7M. In comparison, HLKKF has a market cap of 8.7K. Regarding current trading prices, HERB is priced at $0.03, while HLKKF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HERB currently has a P/E ratio of 0.02, whereas HLKKF's P/E ratio is N/A. In terms of profitability, HERB's ROE is +0.03%, compared to HLKKF's ROE of -10.09%. Regarding short-term risk, HERB is less volatile compared to HLKKF. This indicates potentially lower risk in terms of short-term price fluctuations for HERB.Check HLKKF's competition here
HERB vs TAER Comparison June 2026
HERB plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HERB stands at 4.7M. In comparison, TAER has a market cap of 5.7K. Regarding current trading prices, HERB is priced at $0.03, while TAER trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HERB currently has a P/E ratio of 0.02, whereas TAER's P/E ratio is -0.02. In terms of profitability, HERB's ROE is +0.03%, compared to TAER's ROE of +0.44%. Regarding short-term risk, HERB is less volatile compared to TAER. This indicates potentially lower risk in terms of short-term price fluctuations for HERB.Check TAER's competition here
HERB vs FFRMF Comparison June 2026
HERB plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HERB stands at 4.7M. In comparison, FFRMF has a market cap of 1.7K. Regarding current trading prices, HERB is priced at $0.03, while FFRMF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HERB currently has a P/E ratio of 0.02, whereas FFRMF's P/E ratio is N/A. In terms of profitability, HERB's ROE is +0.03%, compared to FFRMF's ROE of -2.83%. Regarding short-term risk, HERB is less volatile compared to FFRMF. This indicates potentially lower risk in terms of short-term price fluctuations for HERB.Check FFRMF's competition here
HERB vs BIQIF Comparison June 2026
HERB plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HERB stands at 4.7M. In comparison, BIQIF has a market cap of 1K. Regarding current trading prices, HERB is priced at $0.03, while BIQIF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HERB currently has a P/E ratio of 0.02, whereas BIQIF's P/E ratio is N/A. In terms of profitability, HERB's ROE is +0.03%, compared to BIQIF's ROE of +0.01%. Regarding short-term risk, HERB is less volatile compared to BIQIF. This indicates potentially lower risk in terms of short-term price fluctuations for HERB.Check BIQIF's competition here
HERB vs GLGLF Comparison June 2026
HERB plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HERB stands at 4.7M. In comparison, GLGLF has a market cap of 384. Regarding current trading prices, HERB is priced at $0.03, while GLGLF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HERB currently has a P/E ratio of 0.02, whereas GLGLF's P/E ratio is N/A. In terms of profitability, HERB's ROE is +0.03%, compared to GLGLF's ROE of -0.10%. Regarding short-term risk, HERB is less volatile compared to GLGLF. This indicates potentially lower risk in terms of short-term price fluctuations for HERB.Check GLGLF's competition here
HERB vs URBF Comparison June 2026
HERB plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HERB stands at 4.7M. In comparison, URBF has a market cap of 250. Regarding current trading prices, HERB is priced at $0.03, while URBF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HERB currently has a P/E ratio of 0.02, whereas URBF's P/E ratio is N/A. In terms of profitability, HERB's ROE is +0.03%, compared to URBF's ROE of -56.17%. Regarding short-term risk, HERB is less volatile compared to URBF. This indicates potentially lower risk in terms of short-term price fluctuations for HERB.Check URBF's competition here
HERB vs CFPI Comparison June 2026
HERB plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HERB stands at 4.7M. In comparison, CFPI has a market cap of 192. Regarding current trading prices, HERB is priced at $0.03, while CFPI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HERB currently has a P/E ratio of 0.02, whereas CFPI's P/E ratio is N/A. In terms of profitability, HERB's ROE is +0.03%, compared to CFPI's ROE of +0.03%. Regarding short-term risk, HERB is more volatile compared to CFPI. This indicates potentially higher risk in terms of short-term price fluctuations for HERB.Check CFPI's competition here
HERB vs KALRQ Comparison June 2026
HERB plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HERB stands at 4.7M. In comparison, KALRQ has a market cap of 92. Regarding current trading prices, HERB is priced at $0.03, while KALRQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HERB currently has a P/E ratio of 0.02, whereas KALRQ's P/E ratio is N/A. In terms of profitability, HERB's ROE is +0.03%, compared to KALRQ's ROE of -0.19%. Regarding short-term risk, HERB is more volatile compared to KALRQ. This indicates potentially higher risk in terms of short-term price fluctuations for HERB.Check KALRQ's competition here
HERB vs OCESP Comparison June 2026
HERB plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HERB stands at 4.7M. In comparison, OCESP has a market cap of 0. Regarding current trading prices, HERB is priced at $0.03, while OCESP trades at $16.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HERB currently has a P/E ratio of 0.02, whereas OCESP's P/E ratio is N/A. In terms of profitability, HERB's ROE is +0.03%, compared to OCESP's ROE of N/A. Regarding short-term risk, HERB is more volatile compared to OCESP. This indicates potentially higher risk in terms of short-term price fluctuations for HERB.Check OCESP's competition here
HERB vs BYIN Comparison June 2026
HERB plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HERB stands at 4.7M. In comparison, BYIN has a market cap of 0. Regarding current trading prices, HERB is priced at $0.03, while BYIN trades at $4.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HERB currently has a P/E ratio of 0.02, whereas BYIN's P/E ratio is N/A. In terms of profitability, HERB's ROE is +0.03%, compared to BYIN's ROE of +0.32%. Regarding short-term risk, HERB is more volatile compared to BYIN. This indicates potentially higher risk in terms of short-term price fluctuations for HERB.Check BYIN's competition here
HERB vs CAOX Comparison June 2026
HERB plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HERB stands at 4.7M. In comparison, CAOX has a market cap of 0. Regarding current trading prices, HERB is priced at $0.03, while CAOX trades at $420.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HERB currently has a P/E ratio of 0.02, whereas CAOX's P/E ratio is N/A. In terms of profitability, HERB's ROE is +0.03%, compared to CAOX's ROE of N/A. Regarding short-term risk, HERB is more volatile compared to CAOX. This indicates potentially higher risk in terms of short-term price fluctuations for HERB.Check CAOX's competition here
HERB vs TSLLF Comparison June 2026
HERB plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HERB stands at 4.7M. In comparison, TSLLF has a market cap of 0. Regarding current trading prices, HERB is priced at $0.03, while TSLLF trades at $3.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HERB currently has a P/E ratio of 0.02, whereas TSLLF's P/E ratio is 19.15. In terms of profitability, HERB's ROE is +0.03%, compared to TSLLF's ROE of N/A. Regarding short-term risk, HERB is more volatile compared to TSLLF. This indicates potentially higher risk in terms of short-term price fluctuations for HERB.Check TSLLF's competition here